Samantha Semenkow

Stock Analyst at Citigroup

(2.51)
# 3148
Out of 5,446 analysts
53
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
WVE WAVE Life Sciences
Initiates Coverage On: Buy
16
9.45 69.31% 1 Jul 16, 2025
PRME Prime Medicine
Downgrades: Neutral
10 2
3.24 -53.7% 3 May 27, 2025
CABA Cabaletta Bio
Maintains: Buy
17 13
1.58 722.78% 3 May 16, 2025
ALLO Allogene Therapeutic...
Maintains: Buy
8 4
1.06 277.36% 3 May 15, 2025
ARGX argenx
Maintains: Strong Buy
796 803
661.36 21.42% 6 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
18.57 223.1% 1 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 5
4.44 12.61% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 3
2.27 32.16% 2 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
3.35 258.21% 1 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 31
20.34 52.41% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 15
3.46 333.53% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
80
7.75 932.26% 2 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 14
3.77 271.35% 6 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 15
2.67 461.8% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 12
5 140% 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
72
54.14 32.99% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
56.99 -19.28% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
33 50
14.81 237.61% 3 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 56
16.06 248.69% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 1
n/a n/a 3 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.54 289.61% 1 May 3, 2023